NovoLog users can avoid a price spike by switching to another insulin, Humalog per United Healthcare and this is all a shake up of a bidding/contract situation, so who ever comes in at the lower bid moves to the cheap spot at tier 1 and the other ends up at the top level at tier 3, but no tier 2 in the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Dec 6 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, Medical Devices, FDA, Diabetes, insulin, Heatlhcare, China, UnitedHealthcare, Mergers and Acquisitions, Ingenix, Formularies, tiers, i3, ChinaGate